vive summary vive reformulates existing pesticides for the $46 billion crop protection industry,...
TRANSCRIPT
2
Vive Summary• Vive reformulates existing pesticides for the $46 Billion crop
protection industry, addressing issues jeopardizing the industry
• Replace organic solvents with biodegradable or bio-inert polymers
• Working with six global crop protection companies on products with $8 billion total addressable market
• Six products in field trials with results expected by year end
• Trials demonstrate Vive formulations are more effective than current products
• Products and process are patented and are 100% owned
• Experienced management team and advisors
• Raised $16 MM to date
3
Crop Yields are a Worldwide Issue • Population growth• Shrinking arable land• Changing diets• Biofuels
$46Bpesticide industry
The Growing Use of Pesticides is Assured
Yet Industry Profits are Under Pressure
Patent Cliff
Lack ofNew Molecules
RegulatoryBarriers
Crop Protection IndustrySyngenta | Bayer | BASF | DuPont | Dow
Pressure from Generics4
Addressing Crop Protection Industry’s Key Issues
Patentable Competitive Approvable
• New IP without new active ingredient
• Economics• Efficacy• Convenience• Grower safety
• Avoid toxic formulations
• Environmental safety
5
Products
Vive Patented Technology Platform
IP Generating Innovative Approvable
• Broadly applicable reformulation technology
• Lower development cost per product
• Improves economics, efficacy, safety, convenience
• Fast timelines
• Improves handling and safety
• Enables water to act as the only solvent
6
Active Ingredient (AI) Vive Cage Vive New Product
Vive Technology
Not soluble in water Encapsulates AI in a water dispersible (non-toxic) structure
Encapsulated AIdispersed in water
77
8
Vive Technology Platform
Water and bio-inert polymers create a cage that delivers the active ingredient
• Low capital cost — uses off the shelf equipment
• Main inputs are EPA approved polymers
• Straightforward path to large commercial scale
• $4 MM capex for 200T Allosperse plant
Pilot Scale Plant (Five tonnes per year)
Simple, Scalable Manufacturing
99
10
6,000 Tonnes of packaged
product with >$100 MM in
annual revenue
Vive 200 Tonne plant
Low Capex with Significant Product Leverage
600 Tonnes of partner supplied active ingredient
• 12 issued patents (first expiry 2017)
• 52 patents pending
• 7 families in the US and internationally
• New products via patentable reformulations
• First reformulated product patents to be filed in 2012
Four Levels of IP Protection
Patent Cliff
Ongoing IP Generation11
Product IP
Application IP
Process IP
Composition of Matter IP
Patented Actives Generic Actives
• Developing products with branded companies
• $5 Billion+ addressable market
• Upfront, milestone and royalty revenue
• Developing products to be distributed through branded companies
• $3 Billion+ addressable market
• Product revenue
Portfolio Renewal and Extension Model12
Vive Product Portfolio
Partnered Product
13
Improved Insecticide Efficacy
Treatment Pests Killed
Plant Damage(Lower is Better)
Vive 90% 1.1%
Ammo 5% 32.5%
• Third party trials tested Vive’s formulated cypermethrin versus the leading competitive product, FMC’s Ammo
• Both products were applied at 0.1ppm
• Tests demonstrated superior performance killing pests and protecting plants
• Results have been confirmed in 5 different trials
What Does it Mean to the Farmer?
Potential product benefits include:
• Better plant protection – higher yields
• Buy and use less pesticide – save money
Vive’s formulation was 18x more effective killing pests and ~30x more effective protecting plants from insect damage
Partnered Product
14
Improved Residual Activity• Trials test how long a product keeps working after
it is applied
• Third party trials tested Vive’s formulated lambda-cyhalothrin versus the leading premium product, Syngenta’s Karate Zeon, at identical concentrations
• Karate Zeon is marketed against “standard” products based on its superior residual activity
• Results show that Vive’s formulation is better after 7 and 14 days
What Does it Mean to the Farmer?
Potential product benefits include:
• Sustained protection – higher yields, better crops
• Apply less often – save money and hassle
Treatment Pests Killed7 Days Later
Pests Killed14 Days Later
Vive 90% 76%
Karate Zeon 50% 42%
Vive’s formulation was 80% more effective killing pests both one and two weeks after application
15
Potential Markets
Pharmaceuticals
TAM => $500 Bn
Beauty and Personal CareTAM => $425
Bn
Crop ProtectionTAM => $50 Bn
NutritionalsTAM => $100
Bn
IndustrialTAM => $300
Bn
Potential Markets > $1 Trillion
Keith ThomasCEO
Entrepreneur, project management and corporate finance; Booz Allen, Citigroup, BASc (Toronto), MA (Toronto), MBA (Columbia)
Darren AndersonCTO
Founding president, 4 issued patents, 24 pending applications, 10 refereed papers, over 40 conference presentations and publications, PhD (Toronto)
Flavio CampagnaroVP Manufacturing
Senior process engineer, scaled large environmental plants; Bennett Environmental, BASc (UBC), PEng
Skip CampbellVP Product Creation
Boston-based M&A and advisory for high-tech industries, consulting and VC experience, BA (Williams), MBA (Toronto)
Ken YoonCFO and VP Corp Development
Life sciences venture capitalist, consulting and accounting; VenGrowth, Ernst & Young, BSc (Western), LLB (Queen’s), MBA (Toronto), CA
Management
17
Supplemented by 10 advisors with experience at Syngenta, BASF, DuPont, Dow, FMC ,etc.
Neil ReidChair Co-founder, MDS Sciex
Charlie FischerDirector
Former CEO, Dow AgroSciences; Former Chair, CropLife America and CropLife International
Warren LibbyDirector
Former President, Syngenta Canada; Former Chairman, Crop Protection Institute of Canada
Bill LambertDirector Chairman, Ag Growth International; Former Partner, TD Capital
Mark MacDonaldDirector Former VP, Teachers Private Equity; significant board experience
Directors
181818
19
The Vive Opportunity
$46 Billion global market opportunity with assured demand with
significant potential in additional markets
Patent cliff, formulation issues and generics are unavoidable
Disruptive, patented, green technology addresses industry needs
Products with $8 Billion addressable market in dev and trials
Strong management team and directors
Commercial deals in 2013 and product launches in 2014